Invention Grant
US08394801B2 Quinoxaline derivatives and their use for treating benign and malignant tumour disorders
失效
喹喔啉衍生物及其用于治疗良性和恶性肿瘤疾病的用途
- Patent Title: Quinoxaline derivatives and their use for treating benign and malignant tumour disorders
- Patent Title (中): 喹喔啉衍生物及其用于治疗良性和恶性肿瘤疾病的用途
-
Application No.: US12731243Application Date: 2010-03-25
-
Publication No.: US08394801B2Publication Date: 2013-03-12
- Inventor: Matthias Gerlach , Irene Seipelt , Eckhard Guenther , Tilmann Schuster , Emmanuel Polymeropoulos , Michael Czech , Eckhard Claus
- Applicant: Matthias Gerlach , Irene Seipelt , Eckhard Guenther , Tilmann Schuster , Emmanuel Polymeropoulos , Michael Czech , Eckhard Claus
- Applicant Address: DE Frankfurt am Main
- Assignee: Aeterna Zentaris GmbH
- Current Assignee: Aeterna Zentaris GmbH
- Current Assignee Address: DE Frankfurt am Main
- Agency: Oblon, Spivak, McClelland, Maier & Neustadt, L.L.P.
- Priority: EP09157141 20090402
- Main IPC: A61K31/495
- IPC: A61K31/495
Abstract:
The invention provides quinoxalines of the general formula I which are used as medicaments preferably for treating tumour disorders, in particular in cases of drug resistance to other active compounds and in cases of metastasic carcinoma. The possible applications are not limited to tumour disorders.
Public/Granted literature
- US20100266538A1 QUINOXALINE DERIVATIVES AND THEIR USE FOR TREATING BENIGN AND MALIGNANT TUMOUR DISORDERS Public/Granted day:2010-10-21
Information query
